Gujarat Technological University to host country’s first pharma hackathon

AHMEDABAD: In a breakthrough initiative, Gujarat Technological University (GTU) is set to host the world’s first pharma hackathon in Ahmedabad. While hackathon events are held globally across the design, engineering and information technology sectors, this is the first time it will be held for the pharma sector. According to university sources, the event will be held in the first term of the academic year 2019-20.

A GTU source said, “The pharma hackathon is a problem-solving competition, where students will be given with problems relating to the pharma sector, for which they need to come up with solutions. These issues may be specific to industry or national healthcare, for which pharmaceutical solutions may be offered.”

“Gujarat houses 40% of the pharmaceutical companies in the country, both big and small. Industrial units often come across issues which can be resolved through research and development (R&D). The idea behind the pharma hackathon is to encourage students to come up with innovative technological solutions to industry issues,” said Navin Sheth, vice-chancellor of GTU.

The university has taken an in-principle decision to hold the event and has formed a four-member committee of pharma experts to sort out the modalities. A top source confirmed that representatives of the Indian Drug Manufacturers Association (IDMA) have also been roped-in.

“The problems put to students will mainly be industrial issues and an industry representative will help decide these. While larger companies have separate R&D units, smaller firms often are unable to invest in R&D. This competition will be a medium to come up with innovative solutions,” the source explained.

Sources confirmed that Dr Shrenik Shah, vice-president of IDMA along and Dr C N Patel, dean of the faculty of pharmacy at GTU, are among the committee members.

On the eligibility criteria, varsity officials said a final decision is yet to be taken and there will be more clarity once the committee meets. The general consensus is to keep the event open to senior graduate-level students (i.e. third and fourth year students), postgraduates and doctoral scholars.

  • Related Posts

    WHO launches new primary health care course to strengthen health systems globally

    Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    WHO launches new primary health care course to strengthen health systems globally

    WHO launches new primary health care course to strengthen health systems globally

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert